89 related articles for article (PubMed ID: 22313623)
1. The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.
Younossi ZM; Birerdinc A; Estep M; Stepanova M; Afendy A; Baranova A
J Transl Med; 2012 Feb; 10():25. PubMed ID: 22313623
[TBL] [Abstract][Full Text] [Related]
2. Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy.
Hsu CS; Hsu SJ; Chen HC; Tseng TC; Liu CH; Niu WF; Jeng J; Liu CJ; Lai MY; Chen PJ; Kao JH; Chen DS
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3719-24. PubMed ID: 21321200
[TBL] [Abstract][Full Text] [Related]
3. Review article: genetic factors that modify the outcome of viral hepatitis.
Stättermayer AF; Scherzer T; Beinhardt S; Rutter K; Hofer H; Ferenci P
Aliment Pharmacol Ther; 2014 May; 39(10):1059-70. PubMed ID: 24654629
[TBL] [Abstract][Full Text] [Related]
4. Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha.
da Silva AMV; Alvarado-Arnez LE; Azamor T; Batista-Silva LR; Leal-Calvo T; Bezerra OCL; Ribeiro-Alves M; Kehdy FSG; Neves PCDC; Bayma C; da Silva J; de Souza AF; Muller M; de Andrade EF; Andrade ACM; Dos Santos EM; Xavier JR; Maia MLS; Meireles RP; Cuni HN; Sander GB; Picon PD; Matos DCS; Moraes MO
Front Cell Infect Microbiol; 2021; 11():656393. PubMed ID: 34307188
[TBL] [Abstract][Full Text] [Related]
5. Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C.
Rotman Y; Noureddin M; Feld JJ; Guedj J; Witthaus M; Han H; Park YJ; Park SH; Heller T; Ghany MG; Doo E; Koh C; Abdalla A; Gara N; Sarkar S; Thomas E; Ahlenstiel G; Edlich B; Titerence R; Hogdal L; Rehermann B; Dahari H; Perelson AS; Hoofnagle JH; Liang TJ
Gut; 2014 Jan; 63(1):161-9. PubMed ID: 23396509
[TBL] [Abstract][Full Text] [Related]
6. IL28B polymorphism is not associated with HCV protease diversity in patients co-infected with HIV and HCV treated with pegylated interferon and ribavirin.
Osinusi A; Chary A; Winters MA; Naggie S; Masur H; Polis MA; Kottilil S; Holodniy M
J Med Virol; 2012 Oct; 84(10):1522-7. PubMed ID: 22930497
[TBL] [Abstract][Full Text] [Related]
7. Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.
Huang Y; Feld JJ; Sapp RK; Nanda S; Lin JH; Blatt LM; Fried MW; Murthy K; Liang TJ
Gastroenterology; 2007 Feb; 132(2):733-44. PubMed ID: 17258724
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alfa, interferon-lambda and hepatitis C.
O'Brien TR
Nat Genet; 2009 Oct; 41(10):1048-50. PubMed ID: 19749756
[TBL] [Abstract][Full Text] [Related]
9. The Distribution of Genotype and Allelic Frequency of IL28B Gene Polymorphism in Andhra Pradesh, India.
Sivaprasad S; Rao PN; Gupta R; Ashwini K; Reddy DN
J Clin Exp Hepatol; 2012 Jun; 2(2):112-5. PubMed ID: 25755419
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation of the IL-28B promoter affecting gene expression.
Sugiyama M; Tanaka Y; Wakita T; Nakanishi M; Mizokami M
PLoS One; 2011; 6(10):e26620. PubMed ID: 22046316
[TBL] [Abstract][Full Text] [Related]
11. Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo.
Abdel-Mohsen M; Deng X; Danesh A; Liegler T; Jacobs ES; Rauch A; Ledergerber B; Norris PJ; Günthard HF; Wong JK; Pillai SK
PLoS One; 2014; 9(10):e109220. PubMed ID: 25275557
[TBL] [Abstract][Full Text] [Related]
12. Favorable Genotypes of Type III Interferon Confer Risk of Dyslipidemia in the Population With Obesity.
Xu T; Peng B; Liu M; Liu Q; Yang J; Qu M; Liu N; Lin L; Wu J
Front Endocrinol (Lausanne); 2022; 13():871352. PubMed ID: 35784542
[TBL] [Abstract][Full Text] [Related]
13. A Role of Variance in Interferon Genes to Disease Severity in COVID-19 Patients.
Gozman L; Perry K; Nikogosov D; Klabukov I; Shevlyakov A; Baranova A
Front Genet; 2021; 12():709388. PubMed ID: 34603376
[TBL] [Abstract][Full Text] [Related]
14. The role of hepatic progenitor cells in predicting response to therapy in Egyptian patients with chronic hepatitis C, genotype 4.
Helal TEA; Radwan NA; Mahmoud HA; Zaki AM; Ahmed NS; Wahib AA; Aref AM
Afr Health Sci; 2019 Mar; 19(1):1411-1421. PubMed ID: 31148968
[TBL] [Abstract][Full Text] [Related]
15. The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C.
Kadjbaf D; Keshvari M; Alavian SM; Pouryasin A; Behnava B; Salimi S; Mehrnoush L; Karimi Elizee P; Sharafi H
Hepat Mon; 2016 Jun; 16(6):e37011. PubMed ID: 27630727
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4.
Rizk HH; Hamdy NM; Al-Ansari NL; El-Mesallamy HO
PLoS One; 2016; 11(4):e0153895. PubMed ID: 27100663
[TBL] [Abstract][Full Text] [Related]
17. The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.
Domagalski K; Pawłowska M; Kozielewicz D; Dybowska D; Tretyn A; Halota W
PLoS One; 2015; 10(6):e0130899. PubMed ID: 26115415
[TBL] [Abstract][Full Text] [Related]
18. The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.
Egli A; Santer DM; O'Shea D; Tyrrell DL; Houghton M
Emerg Microbes Infect; 2014 Jul; 3(7):e51. PubMed ID: 26038748
[TBL] [Abstract][Full Text] [Related]
19. KPP: KEGG Pathway Painter.
Manyam G; Birerdinc A; Baranova A
BMC Syst Biol; 2015; 9 Suppl 2(Suppl 2):S3. PubMed ID: 25879163
[TBL] [Abstract][Full Text] [Related]
20. Frequency of interleukin 28B rs12979860 C>T variants in Filipino patients chronically infected with hepatitis B virus.
Baclig MO; Reyes KG; Mapua CA; Gopez-Cervantes J; Natividad FF;
Mol Biol Rep; 2015 Mar; 42(3):673-9. PubMed ID: 25391769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
